Show 36 earlier versions
2025-05-22
minor
Study Status, Contacts/Locations v36
2025-03-20
minor
Study Status, Eligibility v35
Eligibility criteria+2,000 characters
1.0 Inclusion Criteria:
1.1 Age > 18 years.
1.2 ECOG/Zubrod performance status (PS) 0, 1, or 2 (reference Appendix C).
1.3 Radiographic findings consistent with non-small cell lung ca [...] d glass opacities with a solid component of 50% or greater.
Those1.4 with ground glass opacities and <50% solid component will be excluded.
The primary tumor in the lung must be biopsy confirmed non-s [...] ll cell lung cancer within 180 days prior to randomization.
1.5 Tumor ≤ 4 cm maximum diameter, including clinical stage IA and selected IB by PET/ or PET integrated with a simultaneous CT scan (PET-CT) of the chest an [...] [...]
2025-02-07
minor
Study Identification, Study Status, Contacts/Locations v34
Study sitesdetails revised at 4 of 48 sites
2024-10-29
minor
Study Identification, Study Status, Contacts/Locations v33
Primary completion date2024-12→2028-12
Completion date2024-12→2028-12
Study sitesdetails revised at 3 of 48 sites
2024-06-05
minor
Study Status, Contacts/Locations v32
Study sitesdetails revised at 1 of 48 sites
2024-03-21
minor
Study Status, Contacts/Locations v31
Study sitesdetails revised at 1 of 48 sites
2024-02-14
minor
Study Status, Contacts/Locations v30
Study sitesdetails revised at 1 of 48 sites
2024-01-03
minor
Study Status, Contacts/Locations v29
Study sitesdetails revised at 5 of 48 sites
2023-12-01
minor
Study Status, Contacts/Locations v28
Study sitesdetails revised at 1 of 48 sites
2023-02-09
minor
Study Status, Contacts/Locations v27
Study sitesdetails revised at 1 of 48 sites
2022-10-05
minor
Study Status, Contacts/Locations v26
Primary completion date2022-12→2024-12
Study sitesdetails revised at 12 of 48 sites
2022-07-12
minor
Study Status, Contacts/Locations v25
Study sites48 entries, revised
AnneLuminis ArundelHealth OncologyResearch CenterInstitute
2022-04-12
minor
Study Status, Contacts/Locations v24
2022-02-11
minor
Study Status, Contacts/Locations v23
Study sitesdetails revised at 1 of 47 sites
2022-01-28
minor
Study Status, Contacts/Locations v22
2021-11-24
minor
Study Status, Eligibility, Contacts/Locations v21
Study sitesdetails revised at 1 of 49 sites
2021-09-28
minor
Study Status, Contacts/Locations v20
Study sitesdetails revised at 5 of 49 sites
2021-07-14
minor
Study Status, Contacts/Locations v19
2021-05-11
minor
Study Status, Sponsor/Collaborators v18
Re-verified, no change to tracked fields
2021-03-30
minor
Study Status, Contacts/Locations v17
2021-03-24
minor
Study Status, Contacts/Locations v16
2020-08-17
minor
Study Status, Contacts/Locations v15
Re-verified, no change to tracked fields
2020-06-11
notable
Active, Not Recruiting→Recruiting Study Status, Contacts/Locations v14
Trial statusActive, Not Recruiting→Recruiting
Study sitesdetails revised at 46 of 46 sites
2020-05-12
notable
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v13
Trial statusRecruiting→Active, Not Recruiting
Study sitesdetails revised at 46 of 46 sites
2020-04-16
minor
Study Status, Contacts/Locations v12
2020-02-06
minor
Study Status, Study Design, Eligibility, Contacts/Locations v11
Eligibility criteria+1,228 characters
[...] glass opacities and <50% solid component will be excluded.
BiopsyThe primary tumor in the lung must be biopsy confirmed non-small cell lung cancer within 180 days prior to randomization.
Tumor ≤ 4 cm maximum diameter, including clinical stage IA [...] PET/CT scan of the chest and upper abdomen performed within 60180 days prior to registrationrandomization.
Repeat imaging within 90 days prior to randomization is recommended for re-staging but is not required based on institutional norms.
All clinically suspicious mediastinal N1, N2, or N3 lymph [...] following methods: mediastinoscopy, anterior mediastino [...]
2019-09-05
minor
Study Status v10
Primary completion date2020-12→2022-12
2018-12-13
minor
Study Status, Contacts/Locations v9
2018-06-12
minor
Study Status, Study Design v8
Primary completion date2018-12→2020-12
Completion date2021-12→2024-12
Enrollment target258→272
2018-05-09
minor
Study Status, Contacts/Locations v7
2018-03-16
minor
Study Status, Contacts/Locations v6
2018-03-01
minor
Study Status, Contacts/Locations v5
2017-10-19
minor
Study Status v4
Re-verified, no change to tracked fields
2016-07-14
minor
Study Status, Contacts/Locations, IPDSharing v3
2016-04-11
minor
Study Status, Eligibility v2
Re-verified, no change to tracked fields
2015-09-12
notable
Not Yet Recruiting→Recruiting Study Status, Study Description, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Study sites0→1
Study description+968 characters
Stereotactic Ablative Radiotherapy has been shown in single institution phase II and matched cohort studies to be effective at controlling primary early lung cancer.
Recent pooled analysis of both the STARS and ROSEL randomized trials comparing SABR versus lobectomy have shown a significantly improv [...] Patients will be accrued and followed for a minimum of 2-years after treatment.